Doctors Note Logo

Published on: 9/28/2026

Reglan Side Effects: Movement Problems and Why Courses Are Kept Short

Reglan (metoclopramide) can cause movement-related side effects, including restlessness, muscle stiffness, tremor, involuntary facial or limb movements, and tardive dyskinesia, which may be permanent. Because this risk rises with longer use and higher cumulative doses, treatment is generally limited to 12 weeks or less, and the drug carries a boxed warning. Several factors influence individual risk, including age, kidney function, diabetes, and other medications, so see below to understand the important details before continuing or stopping therapy.

If you have noticed twitching, tongue or lip movements, inner restlessness, or stiffness while taking this medication, understanding whether your symptoms point to a drug reaction or something else can help you act quickly, since early recognition improves outcomes. Take a free, instant, online symptom check to clarify what may be happening and get guidance on your next steps.

Last reviewed for medical accuracy: 09/28/2026

answer background

Explanation

Reglan Side Effects: Movement Problems and Why Courses Are Kept Short

Reglan (metoclopramide) is a medication often prescribed for heartburn, acid reflux, nausea and vomiting. While it can be effective, one of the most serious concerns is its potential to cause movement-related side effects. Understanding these risks—and why treatment courses are usually kept brief—helps you make informed decisions and discuss options with your doctor.


What Is Reglan and How Does It Work?

  • Mechanism: Reglan blocks dopamine D2 receptors in the brain and the gut. This dual action speeds up stomach emptying and helps control nausea.
  • Common uses:
    • Gastroesophageal reflux disease (GERD)
    • Gastroparesis (slow stomach emptying)
    • Post-surgery or chemotherapy nausea
  • Typical dosage: Varies by condition; often 10 mg up to four times daily, but rarely for more than 12 weeks.

Movement-Related Side Effects (Reglan Side Effects)

Because Reglan interferes with dopamine—a brain chemical that helps regulate movement—it can lead to a range of movement disorders. These side effects can occur at any time, but the risk increases with higher doses and longer use.

1. Acute Dystonic Reactions

  • When they appear: Usually within hours to days of starting Reglan.
  • Symptoms include:
    • Muscle spasms of the face, neck or back
    • Twisting, jerking movements
    • Difficulty speaking or swallowing
  • What to do: Stop Reglan immediately and seek medical help; these reactions often respond to anticholinergic drugs (e.g., benztropine).

2. Parkinsonism

  • Onset: Days to weeks after starting treatment.
  • Symptoms mirror Parkinson’s disease:
    • Tremors (shaking hands)
    • Rigidity (stiff muscles)
    • Bradykinesia (slowed movements)
  • Management: Lowering the dose or stopping Reglan. Doctors may prescribe medications to counteract the effect.

3. Akathisia

  • What it feels like: An intense inner restlessness and constant need to move.
  • Signs:
    • Inability to sit still
    • Pacing or shifting weight from foot to foot
    • Anxiety or agitation
  • Treatment: Dose reduction, adding a beta-blocker or benzodiazepine under medical supervision.

4. Tardive Dyskinesia (TD)

  • Most serious: Often irreversible if not caught early.
  • Timeline: Develops after months of use, but can occur sooner in older adults.
  • Symptoms:
    • Lip smacking, puckering or chewing motions
    • Tongue protrusion
    • Rapid blinking
    • Involuntary movements of the limbs or torso
  • Why it’s concerning: Even after stopping Reglan, TD can persist or worsen.

Why Courses Are Kept Short

Reglan’s risk of movement disorders grows the longer you’re on it. To minimize this risk, guidelines recommend:

  • Limiting use to no more than 12 weeks in most cases.
  • Using the lowest effective dose for the shortest possible time.
  • Monitoring patients closely for early signs of movement issues.

By following these principles, healthcare providers balance the benefits of symptom relief with the goal of preventing potentially irreversible side effects.


Managing Risks and What You Can Do

  1. Discuss your medical history.
    • Parkinson’s disease, other movement disorders or previous reactions to dopamine-blocking drugs raise your risk.
  2. Report new symptoms immediately.
    • Early detection of dystonia or parkinsonism can allow quick intervention.
  3. Follow dosing instructions carefully.
    • Never exceed the prescribed amount or duration.
  4. Consider alternatives.
    • For chronic GERD or gastroparesis, other medications or lifestyle changes may be safer long-term.
  5. Regular check-ins with your doctor.
    • Schedule follow-up visits if you notice any twitching, stiffness or restlessness.

Monitoring Your Symptoms

If you experience unusual movements, restlessness or muscle stiffness, it’s important to get evaluated. You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

free, online symptom check, using the doctor approved Ubie Symptom Checker

This tool can help you clarify your symptoms before speaking with a healthcare professional.


When to Seek Immediate Medical Attention

While many side effects improve after stopping Reglan, some can be life-threatening:

  • Severe muscle spasms causing airway difficulty or inability to swallow
  • Sudden high fever, stiff muscles and confusion (signs of neuroleptic malignant syndrome)
  • Signs of allergic reaction: rash, itching, swelling, dizziness or trouble breathing

If you experience any of these, seek emergency medical care or call your local emergency number right away.


Talking to Your Doctor

Open communication with your healthcare provider ensures you get the benefits of Reglan with the lowest risk:

  • Describe any movement changes—even mild tremors or restlessness.
  • Ask about alternative therapies if you need long-term relief.
  • Confirm the length of your prescription and whether dose adjustments are planned.
  • Discuss whether you should be monitored by a specialist (e.g., neurologist) if you’re at higher risk.

Key Takeaways

  • Reglan helps with nausea, vomiting and certain stomach conditions by blocking dopamine.
  • Movement-related side effects range from acute dystonia to potentially irreversible tardive dyskinesia.
  • Risk increases with higher doses and treatment longer than 12 weeks.
  • Always use the lowest effective dose for the shortest period.
  • Early detection and dose adjustment can prevent or reduce side effects.
  • Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
  • Speak to a doctor about any concerning symptoms or before making changes to your medication.

Your health matters. If you notice any troubling movement changes or other side effects, don’t wait—talk to your doctor as soon as possible.

(References)

  • * Lal S. Pathophysiology and pharmacotherapy of spasmodic torticollis: a review. Can J Neurol Sci. 1979 Nov;6(4):427-35. doi: 10.1017/s0317167100023830. PMID: 94551.

  • * Price P, Debono A, Parkes JD, Marsden CD, Rosenthaler J. Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism. Br J Clin Pharmacol. 1978 Oct;6(4):303-9. doi: 10.1111/j.1365-2125.1978.tb00856.x. PMID: 359016; PMCID: PMC1429466.

  • * Iakimovskiĭ AF. [Neuropharmacological activity of cerucal and haloperidol by intraperitoneal and intrastriatal administration in rats]. Biull Eksp Biol Med. 1991 Dec;112(12):602-4. PMID: 1777621.

  • * Batts KF, Munter DW. Metoclopramide toxicity in an infant. Pediatr Emerg Care. 1998 Feb;14(1):39-41. doi: 10.1097/00006565-199802000-00011. PMID: 9516631.

  • * Anfinson TJ. Akathisia, panic, agoraphobia, and major depression following brief exposure to metoclopramide. Psychopharmacol Bull. 2002 Winter;36(1):82-93. PMID: 12397849.

  • * Adeleye JO, Akinyemi RO, Balogun WO, Onyegbutulem HO. Unusual presentation of thyrotoxicosis--a case report and review of literature. West Afr J Med. 2005 Jul-Sep;24(3):274-7. doi: 10.4314/wajm.v24i3.28215. PMID: 16276712.

  • * Kamata K, Takahashi E, Morioka N, Nakashima K, Iwade M, Ozaki M. [Metoclopramide Induced Acute Dystonia during Intravenous Patient-controlled Analgesia with Droperidol]. Masui. 2015 Oct;64(10):1076-9. PMID: 26742414.

  • * Scorr LM, Factor SA. VMAT2 inhibitors for the treatment of tardive dyskinesia. J Neurol Sci. 2018 Jun 15;389:43-47. doi: 10.1016/j.jns.2018.02.006. Epub 2018 Feb 5. PMID: 29433808.

  • * Holland EL, Saneto RP, Knipper EK. Hypermetabolic Syndrome and Dyskinesia After Neurologic Surgery for Labrune Syndrome: A Case Report. A A Pract. 2020 May;14(7):e01212. doi: 10.1213/XAA.0000000000001212. PMID: 32371820.

  • * Khamis A, Dygulski S. Low-dose metoclopramide-induced dystonia in cannabis withdrawal syndrome manifesting as intractable nausea and vomiting. BMJ Case Rep. 2025 May 16;18(5):e264815. doi: 10.1136/bcr-2025-264815. Epub 2025 May 16. PMID: 40379294.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.